
PMC:7408073 / 85832-86128
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T481 | 118-124 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
T482 | 205-211 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T167 | 99-102 | Body_part | denotes | RAS | http://purl.obolibrary.org/obo/UBERON_0018229 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2934 | 37-40 | Gene | denotes | ACE | Gene:59272 |
2935 | 41-45 | Gene | denotes | ACE2 | Gene:59272 |
2936 | 179-183 | Gene | denotes | ACE2 | Gene:59272 |
2937 | 265-268 | Gene | denotes | ACE | Gene:59272 |
2938 | 269-273 | Gene | denotes | ACE2 | Gene:59272 |
2939 | 234-239 | Chemical | denotes | ZnCl2 | MESH:C016837 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1027 | 46-54 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T1028 | 118-124 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T1029 | 205-211 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T1030 | 213-216 | http://purl.obolibrary.org/obo/CLO_0001046 | denotes | 116 |
T1031 | 282-290 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T30551 | 99-102 | Chemical | denotes | RAS | http://purl.obolibrary.org/obo/CHEBI_63620 |
T24736 | 179-193 | Chemical | denotes | ACE2 inhibitor | http://purl.obolibrary.org/obo/CHEBI_147289 |
T58502 | 184-193 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T53764 | 234-239 | Chemical | denotes | ZnCl2 | http://purl.obolibrary.org/obo/CHEBI_49976 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T419 | 0-296 | Sentence | denotes | (3) In order to evaluate circulating ACE/ACE2 activity, we can determine it by adding fluorogenic (RAS) substrates to plasma samples without (thus considering also the endogenous ACE2 inhibitor present in plasma [116]) or with adding ZnCl2, which is able to induce ACE/ACE2 maximal activity [96]; |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32708755-18223027-20678975 | 213-216 | 18223027 | denotes | 116 |
32708755-25813276-20678976 | 292-294 | 25813276 | denotes | 96 |